How to read this page: this page quotes the text of current FDA drug labels, exactly as stored by OmniRx. It does not rate how serious a combination is, does not say whether it is safe, and does not tell you what to do. Labels change. Before acting on anything here, ask your pharmacist or prescriber, or read the current label on DailyMed (Drug Interactions and Boxed Warning sections).
ℹ️ Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult your physician or pharmacist before making changes to your medications. Full disclosure policy.

This page shows only what two FDA drug labels say about each other. Each quote below is copied word for word from label text stored by OmniRx; table rows are shown as extracted, so column text can run together.

Lisinopril label names spironolactone

Potassium-sparing diuretics (spironolactone, amiloride, triamterene, and others) can increase the risk of hyperkalemia.
Drug Interactions section of the Lisinopril label. Label set ID 021831ab-dfeb-40fc-aede-4aa1fbb8d918, version 1, effective 2023-08-18. Open on DailyMed. Named in 18 of 18 labels read for this ingredient.

Spironolactone label names a drug class that FDA also assigns to lisinopril

FDA's own class record for lisinopril: Angiotensin-converting Enzyme Inhibitors [MoA]; Angiotensin Converting Enzyme Inhibitor [EPC]. Sources: NLM RxClass. This product uses publicly available data from the U.S. National Library of Medicine (NLM). Whether the class statement below applies to lisinopril depends on the label's own wording.

Check serum potassium levels when ACE inhibitor or ARB therapy is altered in patients receiving spironolactone.
Drug Interactions section of the Spironolactone label. Label set ID 08738ad4-1607-4d55-af71-6790477353bd, version 10, effective 2026-10-08. Open on DailyMed.
This risk is increased by impaired renal function or concomitant potassium supplementation, potassium-containing salt substitutes or drugs that increase potassium, such as angiotensin converting enzyme inhibitors and angiotensin receptor blockers [see Drug Interactions (7.1) ] .
Warnings and Precautions section of the Spironolactone label. Label set ID 08738ad4-1607-4d55-af71-6790477353bd, version 10, effective 2026-10-08. Open on DailyMed.

What this page does not cover

OmniRx has not extracted a passage from the spironolactone labels that names lisinopril. That means only that none is shown here. The spironolactone labels may say more, so read the full current labels on DailyMed.

Where this comes from

FDA drug label text via openFDA (public domain), US labels only, stored in OmniRx edition 2026-11 (root 98912c55a72b), read on 2026-11-13. A passage here is a record that a label names a drug, not a finding that the two interact. Ask your pharmacist or prescriber about your own medicines, and do not start, stop or change a medicine because of anything on this site.

Other interaction pages